Journal article

Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea

C Barnadas, L Timinao, S Javati, J Iga, E Malau, C Koepfli, LJ Robinson, N Senn, B Kiniboro, L Rare, JC Reeder, PM Siba, PA Zimmerman, H Karunajeewa, TM Davis, I Mueller

Malaria Journal | BMC | Published : 2015

Abstract

Background: Drug resistance remains a major obstacle to malaria treatment and control. It can arise and spread rapidly, and vary substantially even at sub-national level. National malaria programmes require cost-effective and timely ways of characterizing drug-resistance at multiple sites within their countries. Methods: An improved multiplexed post-PCR ligase detection reaction - fluorescent microsphere assay (LDR-FMA) was used to simultaneously determine the presence of mutations in chloroquine resistance transporter (crt), multidrug resistance 1 (mdr1), dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes in Plasmodium falciparum (n = 727) and Plasmodium vivax (n = 574..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Fogarty International Center


Funding Acknowledgements

This study was supported by grants from Fogarty International Center (TW007872 and TW007377), and the Australian National Health Medical Research Council (#1010203). The Bill & Melinda Gates Foundation funded the original clinical studies under which the samples were collected. TMD was supported by an NHMRC Practitioner Fellowship (#1058260), IM by an NHMRC Senior Research Fellowship (#1043345), HK by an NHMRC Career Development Fellowship (#1064772) and LJR by an NHMRC Early Career Fellowship (#1016443).